|
WO2021079795A1
|
|
Layered transdermal patch
|
|
WO2021065697A1
|
|
Layered patch
|
|
WO2020218249A1
|
|
Lidocaine-containing patch
|
|
WO2020130084A1
|
|
Anti-inflammatory analgesic external preparation
|
|
WO2020095975A1
|
|
Transdermal patch containing fentanyl as active ingredient
|
|
WO2020071546A1
|
|
Preparation stabilized by means of nonaqueous solvent
|
|
CN111836662A
|
|
Adhesive member and microneedle patch
|
|
WO2019151423A1
|
|
Tizanidine therapy system
|
|
CN110913912A
|
|
Non-repositionable patch
|
|
WO2019059376A1
|
|
Topical agent composition containing compound having 6-deoxy-7,8-dihydro-6-oxomorphine skeleton as medicinal component
|
|
US2020085770A1
|
|
Anti-Inflammatory and Analgesic Drug for External Use
|
|
WO2018190313A1
|
|
Memantine-containing transdermally absorbable liquid
|
|
WO2018110510A1
|
|
Microneedle patch
|
|
US2017273974A1
|
|
Patch preparations with misuse prevention features
|
|
WO2017164084A1
|
|
Patch preparation having misuse prevention characteristics
|
|
EP3395397A1
|
|
Microneedle patch applicator and housing for same
|
|
CN108348477A
|
|
Transdermic absorbent delivery device and its manufacturing method
|
|
US2017056502A1
|
|
Percutaneous absorption composition
|
|
US2017056503A1
|
|
Patch preparation containing an acid scavenger
|
|
EP3299012A1
|
|
Transdermal liquid preparation
|
